Trials / Conditions / Ductal Adenocarcinoma of the Pancreas
Ductal Adenocarcinoma of the Pancreas
5 registered clinical trials studyying Ductal Adenocarcinoma of the Pancreas — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer NCT04789486 | Dana-Farber Cancer Institute | Phase 1 / Phase 2 |
| Unknown | Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be Replaced by Whipple Over the Splenic Artery: A Be NCT06119776 | National Taiwan University Hospital | — |
| Completed | Study of SBP-101 in Pancreatic Cancer NCT02657330 | Panbela Therapeutics, Inc. | Phase 1 |
| Completed | Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer NCT02047513 | AIO-Studien-gGmbH | Phase 2 |
| Completed | Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer NCT02125136 | AIO-Studien-gGmbH | Phase 2 |